FDA paves way for COVID-19 vaccinations in young kids
WASHINGTON – The Food and Drug Administration has paved the way for children ages 5 to 11 to get Pfizer’s COVID-19 vaccine. The agency authorized the kid-size doses on Friday. They are just a third of the amount given to teens and adults. But there’s one more regulatory hurdle. Next week, advisers to the Centers for Disease Control and Prevention…